The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad423 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Cynthia L Gay und 20 weiteren Autor:innen. Beteiligte Einrichtung: UNC HIV Cure Center, University of North Carolina at Chapel Hill. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
The histone deacetylase inhibitor vorinostat (VOR) can reverse human immunodeficiency virus type 1 (HIV-1) latency in vivo and allow T cells to clear infected cells in vitro. HIV-specific T cells (HXTCs) can be expanded ex vivo and have been safely administered to people with HIV (PWH) on antiretroviral therapy.
Methods
Six PWH received infusions of 2 × 107 HXTCs/m² with VOR 400 mg, and 3 PWH received infusions of 10 × 107 HXTCs/m² with VOR. The frequency of persistent HIV by multiple assays including quantitative viral outgrowth assay (QVOA) of resting CD4+ T cells was measured before and after study therapy.
Results
VOR and HXTCs were safe, and biomarkers of serial VOR effect were detected, but enhanced antiviral activity in circulating cells was not evident. After 2 × 107 HXTCs/m² with VOR, 1 of 6 PWH exhibited a decrease in QVOA, and all 3 PWH exhibited such declines after 10 × 107 HXTCs/m² and VOR. However, most declines did not exceed the 6-fold threshold needed to definitively attribute decline to the study intervention.
Conclusions
These modest effects provide support for the strategy of HIV latency reversal and reservoir clearance, but more effective interventions are needed to yield the profound depletion of persistent HIV likely to yield clinical benefit. Clinical Trials Registration. NCT03212989.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UNC HIV Cure Center, University of North Carolina at Chapel Hill.
- Department of Medicine, University of North Carolina at Chapel Hill.
- Center for Cancer and Immunology Research, Children's National Health System.
- Pediatrics and GW Cancer Center, The George Washington University, Washington, District of Columbia.
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill.
- Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, New Mexico.
ORCID-Profile: David M Margolis
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- Cancer Center Core Support Grant
- UNC Lineberger Comprehensive Cancer Center
- UNC Flow Cytometry Core Facility)
Zitieren
APA
Gay, C. L., Hanley, P. J., Falcinelli, S. D., Kuruc, J. D., Pedersen, S. M., Kirchherr, J., Raines, S. L. M., Motta, C. M., Lazarski, C., Chansky, P., Tanna, J., Shibli, A., Datar, A., McCann, C. D., Sili, U., Ke, R., Eron, J. J., Archin, N., Goonetilleke, N., …, & Margolis, D. M. (2024). The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad423
Vancouver
Gay CL, Hanley PJ, Falcinelli SD, Kuruc JD, Pedersen SM, Kirchherr J, et al. The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad423
BibTeX
@article{Gay2024,
author = {Gay, Cynthia L and Hanley, Patrick J and Falcinelli, Shane D and Kuruc, JoAnn D and Pedersen, Susan M and Kirchherr, Jennifer and Raines, Samuel L M and Motta, Cecilia M and Lazarski, Chris and Chansky, Pamela and Tanna, Jay and Shibli, Abeer and Datar, Anushree and McCann, Chase D and Sili, Uluhan and Ke, Ruian and Eron, Joseph J and Archin, Nancie and Goonetilleke, Nilu and Bollard, Catherine M and Margolis, David M},
title = {The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad423}
}
EUVIMED